Back Stocks profile

Stock analysis tool for investors

Vineet Laboratories Ltd.

NSE: VINEETLAB | BSE:543298

₹58.54 -0.33 (-0.56%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

58.40

Today’s High

60.00

52W low

46.60

52W High

88.90

Open Price

60.00

Prev. Close

58.3000

Volume

54245.00

Value

3175502.30

Fundamentals

Market Cap Cr

54.00

Price to Earnings

52.50

Price to Book Value

1.60

Dividend Yield

0.00

PE to Growth

-2.90

Op Revenue TTM Cr

150.59

Net Profit TTM Cr

1.03

Cash From Operating Activity Cr

-11.43

Return on Equity %

2.95

EMA & SMA

Bullish Moving Averages

5

Bearish Moving Averages

11

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

31.9

Week

28.9

Month

42.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

58.96

PIVOT

First Resistance

59.58

Second Resistance

60.61

Third Resistance

61.23

First Support

57.93

Second Support

57.31

Third Support

56.28

Relative Strength Index

50.09

Money Flow Index

55.86

MACD

0.51

MACD Signal

0.85

Average True Range

3.12

Average Directional Index

38.37

Rate of Change (21)

3.34

Rate of Change (125)

-28.65

Commodity Channel Index

-61.6

Williams %R

-77.3

BETA

1 Month

0.6

3 Month

0.84

1 Year

0.73

3 Year

0.44

PRICE CHANGE ANALYSIS

-0.31%

1 Week

Low

High

56.35

61.39

0.76%

1 Month

Low

High

55.05

66

5.76%

3 Months

Low

High

50.05

66

-24.9%

6 Months

Low

High

46.6

79.8

11.4%

1 Year

Low

High

46.6

88.9

Bigul
26 Jun 2024

Vineet Laboratories Ltd - 543298 - Closure of Trading Window

The Trading Window for the dealing in the securities of the Company will remain closed from 01st July 2024 till 48 hours after the announcement of Standalone Unaudited Financial results for the First Quarter ending on 30th June 2024
Bigul
30 May 2024

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to the provisions of Regulation 33 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the newspaper advertisement of the Audited Financial Results for the Fourth quarter and the Financial Year ended on March 31, 2024 as published in the following newspapers on 30th May, 2024: 1. Financial Express (English Language) 2. Nava Telangana (Telugu Language)
Bigul
30 May 2024

Vineet Laboratories Ltd - 543298 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A (2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have submitted with both the Stock Exchanges on May 28, 2024 the Annual Secretarial Compliance Report issued by a Practicing Company Secretary for the financial year ended on March 31, 2024. However, because of a misprint in the UDIN mentioned on the report, we are hereby submitting the same report (with no changes in the contents from the already filed one on May 28, 2024). The UDIN is specific to Practicing Company Secretary''s profession and does not in anyway relate to the Company.
Bigul
29 May 2024

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)

The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Approved the resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Chief Executive Officer w.e.f May 29, 2024.
Bigul
29 May 2024

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Resignation of Director

The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Taken note of resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Executive Director w.e.f May 29, 2024.
Bigul
29 May 2024

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Change in Management

The Board of Directors of the company in its meeting held today i.e. , on May 29, 2024 has : Taken note of resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Executive Director w.e.f May 29, 2024. Approved the resignation of Mr. Satish Pandurang Samant (DIN : 10294920) from the office of Chief Executive Officer w.e.f May 29, 2024.
Bigul
29 May 2024

Vineet Laboratories Ltd - 543298 - Outcome Of Board Meeting Held On Wednesday, May 29, 2024 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

The Board of Directors of the company in its meeting held today i.e. on May 29, 2024 has: Considered and approved Audited Standalone Financial Results of the Company for the 4th quarter and the financial year ended on 31st March, 2024
Bigul
29 May 2024

Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, May 29, 2024 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

The Board of Directors of the company in its meeting held today i.e., on May 29, 2024 has : Considered and approved Audited Standalone Financial Results of the Company for the 4th quarter and the financial year ended on 31st March, 2024. Taken note of resignation of Mr. Satish Pandurang Samant (DIN:10294920) from the office of Executive Director w.e.f May 29, 2024. Approved the resignation of Mr. Satish Pandurang Samant (DIN:10294920) from the office of Chief Executive Officer w.e.f May 29, 2024.
Bigul
28 May 2024

Vineet Laboratories Ltd - 543298 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby enclosing the Annual Secretarial Compliance Report issued by a Practicing Company Secretary for the financial year ended on March 31, 2024.
Bigul
21 May 2024

Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for Considering And Approving The Audited Standalone Financial Results Of The Company For The 4Th Quarter And The Financial Year Ended On March 31, 2024.

Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve the audited standalone financial results of the Company for the 4th quarter and the financial year ended on March 31, 2024
See all News

FAQs

The latest market price of Vineet Laboratories Ltd. on NSE was Rs. 58.54 as of today.

The opening share price of Vineet Laboratories Ltd. was Rs. 60.00 as of today.

The 52-week high share price of Vineet Laboratories Ltd. was Rs. 88.90.

The 52 week low share price of Vineet Laboratories Ltd. was Rs. 46.60.

Vineet Laboratories Ltd. has a market cap of Rs. 54.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Vineet Laboratories Ltd. is -2.90. Please refer to the Fundamentals section for further details.

The operating revenue for Vineet Laboratories Ltd. in the last FY was Rs.  150.59 crore. Please refer to the Financials section for further details.

The Net Profit for Vineet Laboratories Ltd. in the last FY was Rs. 1.03 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Vineet Laboratories Ltd. was on 2022-09-19 for Rs. 1 per share. According to today’s share price, the dividend yield of Vineet Laboratories Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Vineet Laboratories Ltd..

Close

Let's Open Free Demat Account